Targeted Oncology Staff

One year following treatment with androgen deprivation therapy, a 57-year-old patients with nonmetastatic castration-resistant prostate cancer presented again with a PSA doubling time of 8.6 months and was still nonmetastatic.

In a roundtable discussion with multiple participants, Alicia K. Morgans, MD, MPH, covers prostate-specific membrane antigen and Axumin testing in castration-resistant prostate cancer.

Richard S. Finn, MD and a group of peers discusses that case of a 77-year-old woman who presented to her primary care physician complaining of abdominal pain and fatigue.

In this case scenario, a 59-year-old White man presented with chest pain, cough, and dyspnea. The patient was later diagnosis with non–small cell lung cancer.

An 88-year-old man presented with a nonhealing ulcer on the lateral aspect of his nose. The patient was diagnosed with Basal cell carcinoma.

Haris Ali, MD, discussed a 68-year-old woman who presented to her physician with symptoms of fatigue and abdominal pain lasting 4 months; she also reported increased bruising.

During a Targeted Oncology™ Cased-Based Roundtable event, Meghan Mooradian, MD, discussed the case of a 73-year-old patient with extensive stage-small cell lung cancer.

During a Targeted Oncology Case-Based Roundtable event, Petros Grivas, MD, PhD, discussed the case of a 75-year-old patient with castration-resistant prostate cancer.

A 58-year-old man presented with a solitary nodule on the neck, occasional shortness of breath, and intermittent excessive fatigue. Twelve months after being treated with systemic therapy, symptoms occurred leading the oncologist to discover metastatic disease.

During a Targeted Oncology Case-Base Roundtable event, Yi-Bin A. Chen, MD, discussed options for treating acute and chronic graft versus host disease.

In a roundtable discussion with multiple participants, Alicia K. Morgans, MD, MPH, leads a conversation on germline testing and molecular imaging in castration-resistant prostate cancer.

During a Targeted Oncology Case-Based Roundtable event, John M. Burke, MD, discussed the challenges with treating relapsed or refractory diffuse large B-cell lymphoma with a group of peers.

Two year after being diagnosed with stage II multiple myeloma, a 78-year-old female patient was still receiving daratumumab plus lenalidomide maintenance and presented with mild fatigue during a routine follow-up.

Based on 3 clinical trials, suggest that when managing toxicities in patients with non-metastatic castration-resistant prostate cancer, oncologists should look at the delta instead of the absolute numbers.

During a Targeted OncologyTM Case-Based Roundtable event, Dan J. Raz, MD, MAS, and peers discussed the challenges of testing in lung cancer and treatment.

An otherwise healthy 60-year-old woman, who has quit smoking for 8 years after 13 pack years, presented with a nonproductive cough. The patient was diagnosed with non–small cell lung cancer. Oncologists discuss the scenario during a Case-Based Roundtable event.

A 59-year-old White male presented with chest pain, cough, and dyspnea and an image-guided biopsy revealed poorly differentiated adenocarcinoma of the lung.

In a 75-year-old patient with metastatic castration-resistant prostate cancer, a bone scan taken at 14-month follow-up showed evidence of 2 lesions in the right hip/pelvis, and abdominal/pelvic CT showed a 2.1-cm left pelvic lymphadenopathy.

Meredith McKean, MD, MPH, moderated a Case-Based Roundtable discussion about a 88-year-old patient with Basel cell carcinoma.

Tanios S. Bekaii-Saab, MD, professor, discussed the factors that may influence treatment for a 50-year-old patient with KRAS/BRAF wild-type colorectal cancer as well as the treatment options available.

Eric Nadler, MD, MPP, led a Case-Based Roundtable discussion on treating a 58-year-old man with thyroid cancer.

Six months after being diagnosed with stage T2N0MO prostate cancer, a 75-year-old patient showed a 2.1-cm left pelvic lymphadenopathy on an abdominal/pelvic CT.

In treating patients with bladder cancer, criteria for treatment differ across practices. Ten oncologists from community practices and academia discussed how they would approach treatment of a 66-year old man with advanced bladder cancer.

A diagnosis of stage IV renal cell carcinoma in a 59-year-old- African American patient was the topic of a discussion led by Christopher W. Ryan, MD.

Jared Weiss, MD, led a discussion about a 59-year-old patient with RET-fusion-positive non–small cell lung cancer during a Targeted Oncology Case-Based Roundtable event.

During a Targeted Oncology Cased-Based Roundtable event, Chandler Park, MD, t discussed the case of a 75-year-old patient with metastatic castration-resistant prostate cancer.

During a Targeted Oncology Case-Based Roundtable event, Miguel Albino, MD, of Texas Oncology, discussed the case of a 73-year-old patient with EGFR-mutant non–small cell lung cancer.

Twelve months after a male patient with RET-mutant thyroid cancer was no longer asymptomatic, the patient developed symptoms that led the treating physician to discover metastatic disease.

Cora N. Sternberg, MD, discusses the case of a 66-year-old woman with bladder cancer.

Grzegorz S. Nowakowski, MD and Stephen D. Smith lead other participants of a Case Based Roundtable event in a discussion around treatment for patients with transplant-ineligible diffuse large B-cell lymphoma.